Skip to main content
Livermore
Livermore
ZHEN

Avenir Corp

SEC CIK
0001033475
Latest filing
Aug 13, 2026

CTSO holding history

Cytosorbents Corp in every 13F filed by Avenir Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CTSO overviewAll 13F holders of CTSOFull Q2 2026 holdings

Shares (Q2 2026)
5,189,218
Value
$1.94M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of CTSO by Avenir Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20265,189,218$1.94M0.2%−26,558−0.5%ReducedHolders
Q1 20265,215,776$2.95M0.4%−14,323−0.3%ReducedHolders
Q4 20255,230,099$3.34M0.4%+147,261+2.9%AddedHolders
Q3 20255,082,838$4.75M0.5%+24,301+0.5%AddedHolders
Q2 20255,058,537$6.47M0.7%+13,619+0.3%AddedHolders
Q1 20255,044,918$5.04M0.5%+1,950,972+63.1%AddedHolders
Q4 20243,093,946$2.82M0.3%+118,387+4.0%AddedHolders
Q3 20242,975,559$4.46M0.5%+5,297+0.2%AddedHolders
Q2 20242,970,262$2.09M0.2%−202,434−6.4%ReducedHolders
Q1 20243,172,696$3.01M0.3%+121,294+4.0%AddedHolders
Q4 20233,051,402$3.39M0.3%+334,005+12.3%AddedHolders
Q3 20232,717,397$5.11M0.5%−2,335−0.1%ReducedHolders
Q2 20232,719,732$9.76M0.9%+164,179+6.4%AddedHolders
Q1 20232,555,553$8.61M0.8%+108,464+4.4%AddedHolders
Q4 20222,447,089$3.79M0.4%+132,235+5.7%AddedHolders
Q3 20222,314,854$3.15M0.3%+149,855+6.9%AddedHolders
Q2 20222,164,999$4.74M0.5%−11,510−0.5%ReducedHolders
Q1 20222,176,509$6.94M0.6%+389,234+21.8%AddedHolders
Q4 20211,787,275$7.49M0.6%+391,890+28.1%AddedHolders
Q3 20211,395,385$11.3M1.0%+28,836+2.1%AddedHolders
Q2 20211,366,549$10.3M0.8%+1,007,679+280.8%AddedHolders
Q1 2021358,870$3.12M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.